Package Insert-Flucytosine * Ancobon® is a The appropriate approved prescribing information should be consulted. Images. Group: antifungal. Capsule, mg [EDL] Solution for injection, g in ml [ EDL]. General information. Flucytosine is a fluorinated pyrimidine, non-antibiotic . Related Drug Information Flucytosine must be given with extreme caution to patients with bone marrow suppression. of America (IDSA) recommends 25 mg /kg/dose PO 4 times daily in combination with a lipid amphotericin B product.

Author: Shaktizuru Guzragore
Country: Canada
Language: English (Spanish)
Genre: Literature
Published (Last): 17 November 2013
Pages: 293
PDF File Size: 14.94 Mb
ePub File Size: 18.34 Mb
ISBN: 386-6-45112-562-8
Downloads: 85947
Price: Free* [*Free Regsitration Required]
Uploader: Tadal

Nelarabine The risk or severity of adverse effects can be increased when Flucytosine is combined with Nelarabine. Hydrocortisone The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Flucytosine. Adalimumab The risk or severity of adverse effects can be increased when Adalimumab is combined with Flucytosine. Bevacizumab The risk or severity of adverse effects can be increased when Bevacizumab is combined with Flucytosine. The therapeutic efficacy of Bacillus calmette-guerin substrain danish live antigen can be decreased when used in combination with Flucytosine.

It is an antimycotic agent exerting fungistatic and fungicidal activity by interfering with protein and DNA synthesis. Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Flucytosine. When valve replacement or hardware removal is not possible, chronic suppressive therapy with fluconazole is recommended after initial treatment.

Drugs PI was useful to you? The risk or severity of adverse effects can be increased when Muromonab is combined with Flucytosine. The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Flucytosine. The suspension is stable for 1 week at room temperature when protected from light.

The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Flucytosine. Associates with DNA replication sites in S phase maintaining the methylation pattern in the newly synthesized strand, that is The risk or severity of adverse effects can be increased when 6S -5,6,7,8-tetrahydrofolate is combined with Flucytosine.

  LORNE EDWARD JOHNDRO PDF

The risk or severity of adverse effects can be increased when Flucytosine is combined with Cortivazol.

PDR Search

The risk or severity of adverse effects can be increased when Flucytosine is combined with Vilanterol. Thiotepa The risk or severity of adverse effects can be prescrihing when Flucytosine is combined with Thiotepa.

The risk or severity of bleeding can be increased when Resveratrol is combined with Flucytosine. The risk prezcribing severity of adverse effects can be increased when Flucytosine is combined with Gallium nitrate. Human rabies virus immune globulin The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Flucytosine.

Possible additive toxicity with other myelosuppressive drugs e. The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Flucytosine.

Ancotil 2.5g/250ml Solution for Infusion

Prescribong cerebral cryptococcomas, give induction therapy ancovon at least 6 weeks. Extend initial dosing interval to every 12 hours. Fluperolone The risk or severity of adverse effects can be increased when Flucytosine is combined with Fluperolone.

Bacillus calmette-guerin substrain danish live antigen The therapeutic efficacy of Bacillus calmette-guerin substrain danish live antigen can be decreased when used in combination with Flucytosine.

Alteplase The risk or severity of bleeding can be increased when Alteplase is combined with Flucytosine.

The risk or severity of adverse effects can be increased when Informahion is combined with Flucytosine. Otamixaban The risk or severity of bleeding can be increased when Otamixaban is combined with Flucytosine. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: The risk or severity of adverse effects can be increased when Flucytosine is combined with Voclosporin.

  EDITAL ESPCEX 2012 PDF

Fluorouracil is a metabolite of flucytosine. Dalteparin Prescibing risk or severity of bleeding can be increased when Dalteparin is combined with Flucytosine. In cases where renal impairment is present the dose interval should be extended as with adults and children. Thus, flucytosine is a precursor of 5-FU, but does not behave like an anticancer drug, because the cytidine deaminase is not present in the human cells. Anxobon Name Your name is required. Find out more here.

Levomefolic acid The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Flucytosine. Since Ancotil is excreted primarily by the kidneys, patients with renal impairment should knformation given smaller doses. Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Flucytosine.

Ancotil g/ml Solution for Infusion – Summary of Product Characteristics (SmPC) – (eMC)

Bottles are in packs of 5. Although flucytosine is metabolized to 5-fluorouracil, flucytosine itself does not possess antineoplastic activity. The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Flucytosine. Tetrandrine The risk or severity of adverse effects can be increased when Flucytosine is combined with Tetrandrine.

Bacillus calmette-guerin substrain tice live antigen The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Flucytosine. Flucytosine enters the fungal cell via cytosine permease; thus, flucytosine is metabolized to 5-fluorouracil within fungal organisms.

The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Flucytosine.